Skip to content

West Pharmaceutical Services Inc (WST) stock: revenue, earnings & dividend

West Pharmaceutical Services Inc (WST, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener WST · NYSE Medizintechnik & Messgeräte US-PA

Key figures

Fiscal year
2025
Revenue
3.07 bn $
Revenue growth
6.3 %
Revenue growth 5y (p.a.)
7.4 %
Net income
494 m $
Net margin
16.1 %
Operating margin
19 %
Earnings per share (diluted)
6.79 $
Dividend per share
0.86 $
Payout ratio
12.7 %
Consecutive dividend years
17 years
Consecutive dividend raises
16 years
Dividend growth 5y (p.a.)
5.4 %
Total assets
4.27 bn $
Equity
3.18 bn $
Equity ratio
74.4 %
Return on equity
15.5 %
Cash
791 m $
Operating cash flow
755 m $
Free cash flow
469 m $
Shares outstanding
69,661,036

History

Revenue by fiscal year

2016 1.51 bn $
2017 1.6 bn $
2018 1.72 bn $
2019 1.84 bn $
2020 2.15 bn $
2021 2.83 bn $
2022 2.89 bn $
2023 2.95 bn $
2024 2.89 bn $
2025 3.07 bn $

Net income by fiscal year

2018 207 m $
2019 242 m $
2020 346 m $
2021 662 m $
2022 586 m $
2023 593 m $
2024 493 m $
2025 494 m $

Dividend per share

2016 0.50 $
2017 0.54 $
2018 0.58 $
2019 0.62 $
2020 0.66 $
2021 0.70 $
2022 0.74 $
2023 0.78 $
2024 0.82 $
2025 0.86 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20253.07 bn $494 m $6.79 $0.86 $755 m $
20242.89 bn $493 m $6.69 $0.82 $653 m $
20232.95 bn $593 m $7.88 $0.78 $777 m $
20222.89 bn $586 m $7.73 $0.74 $724 m $
20212.83 bn $662 m $8.67 $0.70 $584 m $
20202.15 bn $346 m $4.57 $0.66 $473 m $
20191.84 bn $242 m $3.21 $0.62 $367 m $
20181.72 bn $207 m $2.74 $0.58 $289 m $
20171.6 bn $–1.99 $0.54 $263 m $
20161.51 bn $–1.91 $0.50 $219 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)